Document:

Exhibit
10.20

 

	Nuvo
                                         Group Ltd.

                                         2021 EMPLOYEE SHARE PURCHASE PLAN

 

Article
I.

PURPOSE

 

The
purpose of this Plan is to assist Eligible Employees of the Company and its Designated Subsidiaries in acquiring a share ownership
interest in the Company.

 

The
Plan consists of two components: (i) the Section 423 Component and (ii) the Non-Section 423 Component. The Section 423 Component
is intended to qualify as an “employee stock purchase plan” under Section 423 of the Code and shall be administered,
interpreted and construed in a manner consistent with the requirements of Section 423 of the Code. The Non-Section 423 Component
authorizes the grant of rights which need not qualify as rights granted pursuant to an “employee stock purchase plan”
under Section 423 of the Code. Rights granted under the Non-Section 423 Component shall be granted pursuant to separate Offerings
containing such sub-plans, appendices, rules or procedures as may be adopted by the Administrator and designed to achieve tax,
securities laws or other objectives for Eligible Employees and Designated Subsidiaries but shall not be intended to qualify as
an “employee stock purchase plan” under Section 423 of the Code. Except as otherwise determined by the Administrator
or provided herein, the Non-Section 423 Component will operate and be administered in the same manner as the Section 423 Component.
Offerings intended to be made under the Non-Section 423 Component will be designated as such by the Administrator at or prior
to the time of such Offering.

 

For
purposes of this Plan, the Administrator may designate separate Offerings under the Plan in which Eligible Employees will participate.
The terms of these Offerings need not be identical, even if the dates of the applicable Offering Period(s) in each such Offering
are identical, provided that the terms of participation are the same within each separate Offering under the Section 423 Component
(as determined under Section 423 of the Code). Solely by way of example and without limiting the foregoing, the Company could,
but shall not be required to, provide for simultaneous Offerings under the Section 423 Component and the Non-Section 423 Component
of the Plan.

 

Article
II.

DEFINITIONS AND CONSTRUCTION

 

Wherever
the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise.

 

2.1
“Administrator” means the entity, including any committee specifically designated by the Board, that
conducts the general administration of the Plan as provided in Article XI.

 

2.2
“Affiliate” means any entity in which the Company has an equity or other ownership interests.

 

2.3
“Agent” means the brokerage firm, bank or other financial institution, entity or person(s), if any,
engaged, retained, appointed or authorized to act as the agent of the Company or an Employee with regard to the Plan.

 

2.4
“Applicable Law” means the requirements relating to the administration of equity incentive plans under
U.S. federal and state securities, tax and other applicable laws, rules and regulations, the applicable rules of any stock exchange
or quotation system on which Shares are listed or quoted and the applicable laws and rules of any non-U.S. country or other jurisdiction
where rights under this Plan are granted.

 

     

     

    

 

2.5
“Board” means the Board of Directors of the Company.

 

2.6
“Code” means the U.S. Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.

 

2.7
“Company” means Nuvo Group Ltd., an Israeli company, or any successor.

 

2.8
“Compensation” of an Eligible Employee means, unless otherwise determined by the Administrator, the
gross base compensation received by such Eligible Employee as compensation for services to the Company or any Designated Subsidiary,
including overtime payments and excluding sales commissions, incentive compensation, bonuses, expense reimbursements, fringe benefits
and other special payments.

 

2.9
“Designated Subsidiary” means any Subsidiary designated by the Administrator in accordance with Section
11.2(b), such designation to specify whether such participation is in the Section 423 Component or Non-Section 423 Component.
A Designated Subsidiary may participate in either the Section 423 Component or Non-Section 423 Component, but not both; provided
that a Subsidiary that, for U.S. tax purposes, is disregarded from the Company or any Subsidiary that participates in the Section
423 Component shall automatically constitute a Designated Subsidiary that participates in the Section 423 Component. The designation
by the Administrator of Designated Subsidiaries and changes in such designations by the Administrator shall not require shareholder
approval. Only entities that are subsidiary corporations of the Company within the meaning of Section 424 of the Code may be designated
as Designated Subsidiaries for purposes of the Section 423 Component, and if an entity does not so qualify, it shall automatically
be deemed to be a Designated Subsidiary in the Non-Section 423 Component.

 

2.10
“Effective Date” means the date upon which the Plan is approved by the shareholders of
the Company, provided that the Board has adopted the Plan on, or within 12 months prior to, such date.

 

2.11
“Eligible Employee” means:

 

(a)
With respect to the Section 423 Component of the Plan, an Employee who does not, immediately after any rights under this Plan
are granted, own (directly or through attribution) share possessing 5% or more of the total combined voting power or value of
all classes of Shares and other securities of the Company, a Parent or a Subsidiary (as determined under Section 423(b)(3) of
the Code). For purposes of the foregoing, the rules of Section 424(d) of the Code with regard to the attribution of share ownership
shall apply in determining the share ownership of an individual, and a share that an Employee may purchase under outstanding options
shall be treated as a share owned by the Employee. With respect to an Employee participating in the Non-Section 423 Component,
such qualification shall not apply, unless otherwise required by Applicable Law.

 

(b)
Notwithstanding the foregoing, the Administrator may provide in an Offering Document that an Employee shall not be eligible to
participate in an Offering Period under the Section 423 Component if: (i) such Employee is a highly compensated employee within
the meaning of Section 423(b)(4)(D) of the Code; (ii) such Employee has not met a service requirement designated by the Administrator
pursuant to Section 423(b)(4)(A) of the Code (which service requirement may not exceed two years); (iii) such Employee’s
customary employment is for twenty hours per week or less; (iv) such Employee’s customary employment is for less than five
months in any calendar year; and/or (v) such Employee is a citizen or resident of a non-U.S. jurisdiction and the grant of a right
to purchase Shares under the Plan to such Employee would be prohibited under the laws of such non-U.S. jurisdiction or the grant
of a right to purchase Shares under the Plan to such Employee in compliance with the laws of such non-U.S. jurisdiction would
cause the Plan to violate the requirements of Section 423 of the Code, as determined by the Administrator in its sole discretion;
provided, further, that any exclusion in clauses (i), (ii), (iii), (iv) or (v) shall be applied in an identical
manner under each Offering Period to all Employees, in accordance with Treasury Regulation Section 1.423-2(e).

 

    2

     

    

 

(c)
With respect to the Non-Section 423 Component, the foregoing rules shall apply in determining who is an “Eligible Employee,”
except (i) the Administrator may limit eligibility further within the Company or a Designated Subsidiary so as to only designate
some Employees of the Company or a Designated Subsidiary as Eligible Employees, and (ii) to the extent the foregoing eligibility
rules are not consistent with applicable local laws, the applicable local laws shall control.

 

2.12
“Employee” means any individual who renders services to the Company or any Designated Subsidiary in
the status of an employee, and, with respect to the Section 423 Component, a person who is an employee within the meaning of Section
3401(c) of the Code. For purposes of an individual’s participation in, or other rights under the Plan, all determinations
by the Company shall be final, binding and conclusive, notwithstanding that any court of law or governmental agency subsequently
makes a contrary determination. For purposes of the Plan, the employment relationship shall be treated as continuing intact while
the individual is on sick leave or other leave of absence approved by the Company or Designated Subsidiary and meeting the requirements
of Treasury Regulation Section 1.421-1(h)(2). Where the period of leave exceeds three (3) months and the individual’s right
to reemployment is not guaranteed either by statute or by contract, the employment relationship shall be deemed to have terminated
on the first day immediately following such three (3)-month period.

 

2.13
“Enrollment Date” means the first Trading Day of each Offering Period.

 

2.14
“Fair Market Value” means, as of any date, the value of Shares determined as follows: (i) if the
Shares are listed on any established stock exchange, its Fair Market Value will be the closing sales price for such Shares as
quoted on such exchange for such date, or if no sale occurred on such date, the last day preceding such date during which a sale
occurred, as reported in The Wall Street Journal or another source the Administrator deems reliable; (ii) if the Shares are
not traded on a stock exchange but are quoted on a national market or other quotation system, the closing sales price on such
date, or if no sales occurred on such date, then on the last date preceding such date during which a sale occurred, as reported
in The Wall Street Journal or another source the Administrator deems reliable; or (iii) without an established market for the
Shares, the Administrator will determine the Fair Market Value in its discretion.

 

2.15
“Non-Section 423 Component” means those Offerings under the Plan, together with the sub-plans, appendices,
rules or procedures, if any, adopted by the Administrator as a part of this Plan, in each case, pursuant to which rights to purchase
Shares during an Offering Period may be granted to Eligible Employees that need not satisfy the requirements for rights to purchase
Shares granted pursuant to an “employee stock purchase plan” that are set forth under Section 423 of the Code.

 

2.16
“Offering” means an offer under the Plan of a right to purchase Shares that may be exercised during
an Offering Period as further described in Article IV hereof. Unless otherwise specified by the Administrator, each Offering to
the Eligible Employees of the Company or a Designated Subsidiary shall be deemed a separate Offering, even if the dates and other
terms of the applicable Offering Periods of each such Offering are identical, and the provisions of the Plan will separately apply
to each Offering. To the extent permitted by Treas. Reg. § 1.423-2(a)(1), the terms of each separate Offering under the Section
423 Component need not be identical, provided that the terms of the Section 423 Component and an Offering thereunder together
satisfy Treas. Reg. § 1.423-2(a)(2) and (a)(3).

 

    3

     

    

 

2.17
“Offering Document” has the meaning given to such term in Section 4.1.

 

2.18
“Offering Period” has the meaning given to such term in Section 4.1.

 

2.19
“Ordinary Shares” means Ordinary Shares, no par value, of the Company and such other securities of the
Company that may be substituted therefore.

 

2.20
“Parent” means any corporation, other than the Company, in an unbroken chain of corporations ending
with the Company if, at the time of the determination, each of the corporations other than the Company owns shares possessing
50% or more of the total combined voting power of all classes of shares in one of the other corporations in such chain.

 

2.21
“Participant” means any Eligible Employee who has executed a subscription agreement and been granted
rights to purchase Shares pursuant to this Plan.

 

2.22
“Payday” means the regular and recurring established day for payment of Compensation to an Employee
of the Company or any Designated Subsidiary.

 

2.23
“Plan” means this 2021 Employee Share Purchase Plan, including both the Section 423 Component and Non-Section
423 Component and any other sub-plans or appendices hereto, as amended from time to time.

 

2.24
“Purchase Date” means the last Trading Day of each Offering Period or such other date as determined
by the Administrator and set forth in the Offering Document.

 

2.25
“Purchase Price” means the purchase price designated by the Administrator in the applicable Offering
Document (which purchase price, for purposes of the Section 423 Component, shall not be less than 85% of the Fair Market Value
of a Share on the Enrollment Date or on the Purchase Date, whichever is lower); provided, however, that, in the
event no purchase price is designated by the Administrator in the applicable Offering Document, the purchase price for the Offering
Periods covered by such Offering Document shall be 85% of the Fair Market Value of a Share on the Enrollment Date or on the Purchase
Date, whichever is lower; provided, further, that the Purchase Price may be adjusted by the Administrator pursuant
to Article VIII and shall not be less than the par value of a Share.

 

2.26
“Section 423 Component” means those Offerings under the Plan, together with the sub-plans, appendices,
rules or procedures, if any, adopted by the Administrator as a part of this Plan, in each case, pursuant to which rights to purchase
Shares during an Offering Period may be granted to Eligible Employees that are intended to satisfy the requirements for rights
to purchase Shares granted pursuant to an “employee stock purchase plan” that are set forth under Section 423 of the
Code.

 

2.27
“Securities Act” means the U.S. Securities Act of 1933, as amended.

 

2.28
“Share” means an Ordinary Share.

 

2.29
“Subsidiary” means any corporation, other than the Company, in an unbroken chain of corporations beginning
with the Company if, at the time of the determination, each of the corporations other than the last corporation in an unbroken
chain owns shares possessing 50% or more of the total combined voting power of all classes of shares in one of the other corporations
in such chain; provided, however, that a limited liability company or partnership may be treated as a Subsidiary to the
extent either (a) such entity is treated as a disregarded entity under Treasury Regulation Section 301.7701-3(a) by reason of
the Company or any other Subsidiary that is a corporation being the sole owner of such entity, or (b) such entity elects to be
classified as a corporation under Treasury Regulation Section 301.7701-3(a) and such entity would otherwise qualify as a Subsidiary.
In addition, with respect to the Non-Section 423 Component, Subsidiary shall include any corporate or non-corporate entity in
which the Company has a direct or indirect equity interest or significant business relationship.

 

    4

     

    

 

2.30
“Trading Day” means a day on which national stock exchanges in the United States are open for trading.

 

2.31
“Treas. Reg.” means U.S. Department of the Treasury regulations.

 

Article
III.

SHARES SUBJECT TO THE PLAN

 

3.1
Number of Shares. Subject to Article VIII, the aggregate number of Shares that may be issued pursuant to rights granted
under the Plan shall be 850,000 Shares. In addition to the foregoing, subject to Article VIII, on the first day of each calendar
year beginning on January 1, 2022 and ending on and including January 1, 2030, the number of Shares available for issuance under
the Plan shall be increased by that number of Shares equal to the lesser of (a) 1.5% of the Shares outstanding on the last day
of the immediately preceding calendar year, as determined on a fully diluted basis, and (b) such smaller number of Shares as may
be determined by the Board. If any right granted under the Plan shall for any reason terminate without having been exercised,
the Shares not purchased under such right shall again become available for issuance under the Plan. Notwithstanding anything in
this Section 3.1 to the contrary, the number of Shares that may be issued or transferred pursuant to the rights granted under
the Section 423 Component of the Plan shall not exceed an aggregate of 850,000 Shares, subject to Article VIII.

 

3.2
Shares Distributed. Any Shares distributed pursuant to the Plan may consist, in whole or in part, of authorized and unissued
Shares, treasury shares or Shares purchased on the open market.

 

Article
IV.

Offering Periods; Offering Documents; Purchase Dates

 

4.1
Offering Periods. The Administrator may from time to time grant or provide for the grant of rights to purchase Shares under
the Plan to Eligible Employees during one or more periods (each, an “Offering Period”) selected by the
Administrator. The terms and conditions applicable to each Offering Period shall be set forth in an “Offering Document”
adopted by the Administrator, which Offering Document shall be in such form and shall contain such terms and conditions as the
Administrator shall deem appropriate and shall be incorporated by reference into and made part of the Plan and shall be attached
hereto as part of the Plan. The provisions of separate Offerings or Offering Periods under the Plan need not be identical.

 

4.2
Offering Documents. Each Offering Document with respect to an Offering Period shall specify (through incorporation of the
provisions of this Plan by reference or otherwise):

 

(a)
the length of the Offering Period, which period shall not exceed twenty-seven months;

 

(b)
the maximum number of Shares that may be purchased by any Eligible Employee during such Offering Period, which, in the absence
of a contrary designation by the Administrator, shall be $25,000 divided by the Fair Market Value of a Share on the Enrollment
Date, which price shall be adjusted if the price per Share is adjusted pursuant to Article VIII; and

 

(c)
such other provisions as the Administrator determines are appropriate, subject to the Plan.

 

    5

     

    

 

Article
V.

ELIGIBILITY AND PARTICIPATION

 

5.1
Eligibility. Any Eligible Employee who shall be employed by the Company or a Designated Subsidiary on a given Enrollment
Date for an Offering Period shall be eligible to participate in the Plan during such Offering Period, subject to the requirements
of this Article V and, for the Section 423 Component, the limitations imposed by Section 423(b) of the Code.

 

5.2
Enrollment in Plan.

 

(a)
Except as otherwise set forth in an Offering Document or determined by the Administrator, an Eligible Employee may become a Participant
in the Plan for an Offering Period by delivering a subscription agreement to the Company by such time prior to the Enrollment
Date for such Offering Period (or such other date specified in the Offering Document) designated by the Administrator and in such
form as the Company provides.

 

(b)
Each subscription agreement shall designate a whole percentage of such Eligible Employee’s Compensation to be withheld by
the Company or the Designated Subsidiary employing such Eligible Employee on each Payday during the Offering Period as payroll
deductions under the Plan. The percentage of Compensation designated by an Eligible Employee may not be less than 1% and may not
be more than the maximum percentage specified by the Administrator in the applicable Offering Document (which percentage shall
be 20% in the absence of any such designation) as payroll deductions. The payroll deductions made for each Participant shall be
credited to an account for such Participant under the Plan and shall be deposited with the general funds of the Company.

 

(c)
A Participant may increase or decrease the percentage of Compensation designated in his or her subscription agreement, subject
to the limits of this Section 5.2, or may suspend his or her payroll deductions, at any time during an Offering Period; provided,
however, that the Administrator may limit the number of changes a Participant may make to his or her payroll deduction
elections during each Offering Period in the applicable Offering Document (and in the absence of any specific designation by the
Administrator, a Participant shall be allowed to decrease (but not increase) his or her payroll deduction elections one time during
each Offering Period). Any such change or suspension of payroll deductions shall be effective with the first full payroll period
following five business days after the Company’s receipt of the new subscription agreement (or such shorter or longer period
as may be specified by the Administrator in the applicable Offering Document). In the event a Participant suspends his or her
payroll deductions, such Participant’s cumulative payroll deductions prior to the suspension shall remain in his or her
account and shall be applied to the purchase of Shares on the next occurring Purchase Date and shall not be paid to such Participant
unless he or she withdraws from participation in the Plan pursuant to Article VII.

 

(d)
Except as otherwise set forth in an Offering Document or determined by the Administrator, a Participant may participate in the
Plan only by means of payroll deduction and may not make contributions by lump sum payment for any Offering Period.

 

5.3
Payroll Deductions. Except as otherwise provided in the applicable Offering Document, payroll deductions for a Participant
shall commence on the first Payday following the Enrollment Date and shall end on the last Payday in the Offering Period to which
the Participant’s authorization is applicable, unless sooner terminated by the Participant as provided in Article VII
or suspended by the Participant or the Administrator as provided in Section 5.2 and Section 5.6, respectively. Notwithstanding
any other provisions of the Plan to the contrary, in non-U.S. jurisdictions where participation in the Plan through payroll deductions
is prohibited, the Administrator may provide that an Eligible Employee may elect to participate through contributions to the Participant’s
account under the Plan in a form acceptable to the Administrator in lieu of or in addition to payroll deductions; provided, however,
that, for any Offering under the Section 423 Component, the Administrator shall take into consideration any limitations under
Section 423 of the Code when applying an alternative method of contribution.

 

    6

     

    

 

5.4
Effect of Enrollment. A Participant’s completion of a subscription agreement will enroll such Participant in the
Plan for each subsequent Offering Period on the terms contained therein until the Participant either submits a new subscription
agreement, withdraws from participation under the Plan as provided in Article VII or otherwise becomes ineligible to participate
in the Plan. 

 

5.5
Limitation on Purchase of Shares. An Eligible Employee may be granted rights under the Section 423 Component only if such
rights, together with any other rights granted to such Eligible Employee under “employee stock purchase plans” of
the Company, any Parent or any Subsidiary, as specified by Section 423(b)(8) of the Code, do not permit such employee’s
rights to purchase shares of the Company or any Parent or Subsidiary to accrue at a rate that exceeds $25,000 of the fair market
value of such shares (determined as of the first day of the Offering Period during which such rights are granted) for each calendar
year in which such rights are outstanding at any time. This limitation shall be applied in accordance with Section 423(b)(8) of
the Code.

 

5.6
Suspension of Payroll Deductions. Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8)
of the Code and Section 5.5 (with respect to the Section 423 Component) or the other limitations set forth in this Plan,
a Participant’s payroll deductions may be suspended by the Administrator at any time during an Offering Period. The balance
of the amount credited to the account of each Participant that has not been applied to the purchase of Shares by reason of Section
423(b)(8) of the Code, Section 5.5 or the other limitations set forth in this Plan shall be paid to such Participant in one
lump sum in cash as soon as reasonably practicable after the Purchase Date.

 

5.7
Non-U.S. Employees. In order to facilitate participation in the Plan, the Administrator may provide for such special terms
applicable to Participants who are citizens or residents of a non-U.S. jurisdiction, or who are employed by a Designated Subsidiary
outside of the United States, as the Administrator may consider necessary or appropriate to accommodate differences in local law,
tax policy or custom. Except as permitted by Section 423 of the Code, with respect to the Section 423 Component, such special
terms may not be more favorable than the terms of rights granted under the Section 423 Component to Eligible Employees who are
residents of the United States. Such special terms may be set forth in an addendum to the Plan in the form of an appendix or sub-plan
(which appendix or sub-plan may be designed to govern Offerings under the Section 423 Component or the Non-Section 423 Component,
as determined by the Administrator). To the extent that the terms and conditions set forth in an appendix or sub-plan conflict
with any provisions of the Plan, the provisions of the appendix or sub-plan shall govern. The adoption of any such appendix or
sub-plan shall be pursuant to Section 11.2(f). Without limiting the foregoing, the Administrator is specifically authorized to
adopt rules and procedures, with respect to Participants who are non-U.S. nationals or employed in non-U.S. jurisdictions, regarding
the exclusion of particular Subsidiaries from participation in the Plan, eligibility to participate, the definition of Compensation,
handling of payroll deductions or other contributions by Participants, payment of interest, conversion of local currency, data
privacy security, payroll tax, withholding procedures, establishment of bank or trust accounts to hold payroll deductions or contributions.

 

5.8
Leave of Absence. During leaves of absence approved by the Company meeting the requirements of Treasury Regulation Section
1.421-1(h)(2) under the Code, a Participant may continue participation in the Plan by making cash payments to the Company on his
or her normal Payday equal to the Participant’s authorized payroll deduction.

 

    7

     

    

 

Article
VI.

grant and Exercise of rights

 

6.1
Grant of Rights. On the Enrollment Date of each Offering Period, each Eligible Employee participating in such Offering
Period shall be granted a right to purchase the maximum number of Shares specified under Section 4.2, subject to the limits
in Section 5.5, and shall have the right to buy, on each Purchase Date during such Offering Period (at the applicable Purchase
Price), such number of whole Shares as is determined by dividing (a) such Participant’s payroll deductions accumulated prior
to such Purchase Date and retained in the Participant’s account as of the Purchase Date, by (b) the applicable Purchase
Price (rounded down to the nearest Share). The right shall expire on the last day of the Offering Period.

 

6.2
Exercise of Rights. On each Purchase Date, each Participant’s accumulated payroll deductions and any other additional
payments specifically provided for in the applicable Offering Document will be applied to the purchase of whole Shares, up to
the maximum number of Shares permitted pursuant to the terms of the Plan and the applicable Offering Document, at the Purchase
Price. No fractional Shares shall be issued upon the exercise of rights granted under the Plan, unless the Offering Document specifically
provides otherwise. Any cash in lieu of fractional Shares remaining after the purchase of whole Shares upon exercise of a purchase
right will be credited to a Participant’s account and carried forward and applied toward the purchase of whole Shares for
the next following Offering Period. Shares issued pursuant to the Plan may be evidenced in such manner as the Administrator may
determine and may be issued in certificated form or issued pursuant to book-entry procedures. 

 

6.3
Pro Rata Allocation of Shares. If the Administrator determines that, on a given Purchase Date, the number of Shares with
respect to which rights are to be exercised may exceed (a) the number of Shares that were available for issuance under the Plan
on the Enrollment Date of the applicable Offering Period, or (b) the number of Shares available for issuance under the Plan on
such Purchase Date, the Administrator may in its sole discretion provide that the Company shall make a pro rata allocation of
the Shares available for purchase on such Enrollment Date or Purchase Date, as applicable, in as uniform a manner as shall be
practicable and as it shall determine in its sole discretion to be equitable among all Participants for whom rights to purchase
Shares are to be exercised pursuant to this Article VI on such Purchase Date, and shall either (i) continue all Offering
Periods then in effect, or (ii) terminate any or all Offering Periods then in effect pursuant to Article IX. The Company
may make pro rata allocation of the Shares available on the Enrollment Date of any applicable Offering Period pursuant to the
preceding sentence, notwithstanding any authorization of additional Shares for issuance under the Plan by the Company’s
shareholders subsequent to such Enrollment Date. The balance of the amount credited to the account of each Participant that has
not been applied to the purchase of Shares shall be paid to such Participant in one lump sum in cash as soon as reasonably practicable
after the Purchase Date or such earlier date as determined by the Administrator. 

 

6.4
Withholding. At the time a Participant’s rights under the Plan are exercised, in whole or in part, or at the time
some or all of the Shares issued under the Plan is disposed of, the Participant must make adequate provision for the Company’s
federal, state, or other tax withholding obligations, if any, that arise upon the exercise of the right or the disposition of
the Shares. At any time, the Company may, but shall not be obligated to, withhold from the Participant’s compensation or
Shares received pursuant to the Plan the amount necessary for the Company to meet applicable withholding obligations, including
any withholding required to make available to the Company any tax deductions or benefits attributable to sale or early disposition
of Shares by the Participant.

 

    8

     

    

 

6.5
Conditions to Issuance of Shares. The Company shall not be required to issue or deliver any certificate or certificates
for, or make any book entries evidencing, Shares purchased upon the exercise of rights under the Plan prior to fulfillment of
all of the following conditions: (a) the admission of such Shares to listing on all stock exchanges, if any, on which the Shares
are then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or
under the rulings or regulations of the Securities and Exchange Commission or any other governmental regulatory body, that the
Administrator shall, in its absolute discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance
from any state or federal governmental agency that the Administrator shall, in its absolute discretion, determine to be necessary
or advisable; (d) the payment to the Company of all amounts that it is required to withhold under federal, state or local law
upon exercise of the rights, if any; and (e) the lapse of such reasonable period of time following the exercise of the rights
as the Administrator may from time to time establish for reasons of administrative convenience. 

 

Article
VII.

WITHDRAWAL; CESSATION OF ELIGIBILITY

 

7.1
Withdrawal. A Participant may withdraw all but not less than all of the payroll deductions credited to his or her account
and not yet used to exercise his or her rights under the Plan at any time by giving written notice to the Company in a form acceptable
to the Company no later than one week prior to the end of the Offering Period. All of the Participant’s payroll deductions
credited to his or her account during an Offering Period shall be paid to such Participant as soon as reasonably practicable after
receipt of notice of withdrawal and such Participant’s rights for the Offering Period shall be automatically terminated,
and no further payroll deductions for the purchase of Shares shall be made for such Offering Period. If a Participant withdraws
from an Offering Period, payroll deductions shall not resume at the beginning of the next Offering Period unless the Participant
timely delivers to the Company a new subscription agreement.

 

7.2
Future Participation. A Participant’s withdrawal from an Offering Period shall not have any effect upon his or her
eligibility to participate in any similar plan that may hereafter be adopted by the Company or a Designated Subsidiary or in subsequent
Offering Periods that commence after the termination of the Offering Period from which the Participant withdraws.

 

7.3
Cessation of Eligibility. Upon a Participant’s ceasing to be an Eligible Employee for any reason, he or she shall
be deemed to have elected to withdraw from the Plan pursuant to this Article VII and the payroll deductions credited to such
Participant’s account during the Offering Period shall be paid to such Participant or, in the case of his or her death,
to the person or persons entitled thereto under Section 12.4, as soon as reasonably practicable, and such Participant’s
rights for the Offering Period shall be automatically terminated. If a Participant transfers employment from the Company or any
Designated Subsidiary participating in the Section 423 Component to any Designated Subsidiary participating in the Non-Section
423 Component, such transfer shall not be treated as a termination of employment, but the Participant shall immediately cease
to participate in the Section 423 Component; however, any contributions made for the Offering Period in which such transfer occurs
shall be transferred to the Non-Section 423 Component, and such Participant shall immediately join the then-current Offering under
the Non-Section 423 Component upon the same terms and conditions in effect for the Participant’s participation in the Section
423 Component, except for such modifications otherwise applicable for Participants in such Offering. A Participant who transfers
employment from any Designated Subsidiary participating in the Non-Section 423 Component to the Company or any Designated Subsidiary
participating in the Section 423 Component shall not be treated as terminating the Participant’s employment and shall remain
a Participant in the Non-Section 423 Component until the earlier of (i) the end of the current Offering Period under the Non-Section
423 Component or (ii) the Enrolment Date of the first Offering Period in which the Participant is eligible to participate following
such transfer. Notwithstanding the foregoing, the Administrator may establish different rules to govern transfers of employment
between entities participating in the Section 423 Component and the Non-Section 423 Component, consistent with the applicable
requirements of Section 423 of the Code.

 

    9

     

    

 

Article
VIII.

Adjustments upon Changes in SHARES

 

8.1
Changes in Capitalization. Subject to Section 8.3, in the event that the Administrator determines that any dividend or
other distribution (whether in the form of cash, Shares, other securities, or other property), change in control, reorganization,
merger, amalgamation, consolidation, combination, repurchase, redemption, recapitalization, liquidation, dissolution, or sale,
transfer, exchange or other disposition of all or substantially all of the assets of the Company, or sale or exchange of Shares
or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company,
or other similar corporate transaction or event, as determined by the Administrator, affects the Shares such that an adjustment
is determined by the Administrator to be appropriate in order to prevent dilution or enlargement of the benefits or potential
benefits intended by the Company to be made available under the Plan or with respect to any outstanding purchase rights under
the Plan, the Administrator shall make equitable adjustments, if any, to reflect such change with respect to (a) the aggregate
number and type of Shares (or other securities or property) that may be issued under the Plan (including, but not limited to,
adjustments of the limitations in Section 3.1 and the limitations established in each Offering Document pursuant to Section 4.2
on the maximum number of Shares that may be purchased); (b) the class(es) and number of Shares and price per Share subject to
outstanding rights; and (c) the Purchase Price with respect to any outstanding rights.

 

8.2
Other Adjustments. Subject to Section 8.3, in the event of any transaction or event described in Section 8.1
or any unusual or nonrecurring transactions or events affecting the Company, any Affiliate of the Company, or the financial statements
of the Company or any Affiliate, or of changes in Applicable Law or accounting principles, the Administrator, in its discretion,
and on such terms and conditions as it deems appropriate, is hereby authorized to take any one or more of the following actions
whenever the Administrator determines that such action is appropriate in order to prevent the dilution or enlargement of the benefits
or potential benefits intended to be made available under the Plan or with respect to any right under the Plan, to facilitate
such transactions or events or to give effect to such changes in laws, regulations or principles:

 

(a)
To provide for either (i) termination of any outstanding right in exchange for an amount of cash, if any, equal to the amount
that would have been obtained upon the exercise of such right had such right been currently exercisable or (ii) the replacement
of such outstanding right with other rights or property selected by the Administrator in its sole discretion;

 

(b)
To provide that the outstanding rights under the Plan shall be assumed by the successor or survivor corporation, or a parent or
subsidiary thereof, or shall be substituted for by similar rights covering the shares of the successor or survivor corporation,
or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and prices;

 

(c)
To make adjustments in the number and type of Shares (or other securities or property) subject to outstanding rights under the
Plan and/or in the terms and conditions of outstanding rights and rights that may be granted in the future;

 

(d)
To provide that Participants’ accumulated payroll deductions may be used to purchase Shares prior to the next occurring
Purchase Date on such date as the Administrator determines in its sole discretion and the Participants’ rights under the
ongoing Offering Period(s) shall be terminated; and

 

(e)
To provide that all outstanding rights shall terminate without being exercised.

 

    10

     

    

 

8.3
No Adjustment Under Certain Circumstances. Unless determined otherwise by the Administrator, no adjustment or action described
in this Article VIII or in any other provision of the Plan shall be authorized to the extent that such adjustment or action
would cause the Section 423 Component of the Plan to fail to satisfy the requirements of Section 423 of the Code.

 

8.4
No Other Rights. Except as expressly provided in the Plan, no Participant shall have any rights by reason of any subdivision
or consolidation of shares of any class, the payment of any dividend, any increase or decrease in the number of shares of any
class or any dissolution, liquidation, merger, or consolidation of the Company or any other corporation. Except as expressly provided
in the Plan or pursuant to action of the Administrator under the Plan, no issuance by the Company of shares of any class, or securities
convertible into shares of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number
of Shares subject to outstanding rights under the Plan or the Purchase Price with respect to any outstanding rights.

 

Article
IX.

Amendment, modification and termination

 

9.1
Amendment, Modification and Termination. The Administrator may amend, suspend or terminate the Plan at any time and from
time to time; provided, however, that approval of the Company’s shareholders shall be required to amend
the Plan to: (a) increase the aggregate number, or change the type, of shares that may be sold pursuant to rights under the Plan
under Section 3.1 (other than an adjustment as provided by Article VIII) or (b) change the corporations or classes of
corporations whose employees may be granted rights under the Plan. 

 

9.2
Certain Changes to Plan. Without shareholder consent and without regard to whether any Participant rights may be considered
to have been adversely affected (and, with respect to the Section 423 Component of the Plan, after taking into account Section
423 of the Code), the Administrator shall be entitled to change the Offering Periods, limit the frequency and/or number of changes
in the amount withheld from Compensation during an Offering Period, establish the exchange ratio applicable to amounts withheld
in a currency other than U.S. dollars, permit payroll withholding in excess of the amount designated by a Participant in order
to adjust for delays or mistakes in the Company’s processing of withholding elections, establish reasonable waiting and
adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Shares for
each Participant properly correspond with amounts withheld from the Participant’s Compensation, and establish such other
limitations or procedures as the Administrator determines in its sole discretion to be advisable that are consistent with the
Plan. 

 

9.3
Actions In the Event of Unfavorable Financial Accounting Consequences. In the event the Administrator determines that the
ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Administrator may, in its discretion
and, to the extent necessary or desirable, modify or amend the Plan to reduce or eliminate such accounting consequence including,
but not limited to: 

 

(a)
altering the Purchase Price for any Offering Period including an Offering Period underway at the time of the change in Purchase
Price;

 

(b)
shortening any Offering Period so that the Offering Period ends on a new Purchase Date, including an Offering Period underway
at the time of the Administrator action; and

 

(c)
allocating Shares.

 

Such
modifications or amendments shall not require shareholder approval or the consent of any Participant.

 

    11

     

    

 

9.4
Payments Upon Termination of Plan. Upon termination of the Plan, the balance in each Participant’s Plan account shall
be refunded as soon as practicable after such termination, without any interest thereon, or the Offering Period may be shortened
so that the purchase of Shares occurs prior to the termination of the Plan.

 

Article
X.

TERM OF PLAN

 

The
Plan shall become effective on the Effective Date. The effectiveness of the Plan shall be subject to approval of the Plan by the
Company’s shareholders within twelve months before or after the date the Plan is first approved by the Board. No right may
be granted under the Plan prior to such shareholder approval. No rights may be granted under the Plan during any period of suspension
of the Plan or after termination of the Plan.

 

Article
XI.

ADMINISTRATION

 

11.1
Administrator. Unless otherwise determined by the Board, the Administrator of the Plan shall be the Compensation Committee
of the Board (or another committee or a subcommittee of the Board to which the Board delegates administration of the Plan). The
Board may at any time vest in the Administrator any authority or duties for administration of the Plan. The Administrator may
delegate administrative tasks under the Plan to the services of an Agent or Employees to assist in the administration of the Plan,
including establishing and maintaining an individual securities account under the Plan for each Participant.

 

11.2
Authority of Administrator. The Administrator shall have the power, subject to, and within the limitations of, the express
provisions of the Plan:

 

(a)
To determine when and how rights to purchase Shares shall be granted and the provisions of each offering of such rights (which
need not be identical).

 

(b)
To designate from time to time which Subsidiaries of the Company shall be Designated Subsidiaries, which designation may be made
without the approval of the shareholders of the Company.

 

(c)
To impose a mandatory holding period pursuant to which Employees may not dispose of or transfer Shares purchased under the Plan
for a period of time determined by the Administrator in its discretion.

 

(d)
To construe and interpret the Plan and rights granted under it, and to establish, amend and revoke rules and regulations for its
administration. The Administrator, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan,
in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective.

 

(e)
To amend, suspend or terminate the Plan as provided in Article IX.

 

    12

     

    

 

(f)
Generally, to exercise such powers and to perform such acts as the Administrator deems necessary or expedient to promote the best
interests of the Company and its Subsidiaries and to carry out the intent that the Plan be treated as an “employee stock
purchase plan” within the meaning of Section 423 of the Code for the Section 423 Component.

 

(g)
The Administrator may adopt sub-plans applicable to particular Designated Subsidiaries or locations, which sub-plans may be designed
to be outside the scope of Section 423 of the Code. The rules of such sub-plans may take precedence over other provisions of this
Plan, with the exception of Section 3.1 hereof, but unless otherwise superseded by the terms of such sub-plan, the provisions
of this Plan shall govern the operation of such sub-plan.

 

11.3
Decisions Binding. The Administrator’s interpretation of the Plan, any rights granted pursuant to the Plan, any subscription
agreement and all decisions and determinations by the Administrator with respect to the Plan are final, binding, and conclusive
on all parties.

 

Article
XII.

MISCELLANEOUS

 

12.1
Restriction upon Assignment. A right granted under the Plan shall not be
transferable other than by will or the applicable laws of descent and distribution, and is exercisable during the Participant’s
lifetime only by the Participant. Except as provided in Section 12.4 hereof, a right under the Plan may not be exercised
to any extent except by the Participant. The Company shall not recognize and shall be under no duty to recognize any assignment
or alienation of the Participant’s interest in the Plan, the Participant’s rights under the Plan or any rights thereunder.

 

12.2
Rights as a Shareholder. With respect to Shares subject to a right granted under the Plan, a Participant shall not be deemed
to be a shareholder of the Company, and the Participant shall not have any of the rights or privileges of a shareholder, until
such Shares have been issued to the Participant or his or her nominee following exercise of the Participant’s rights under
the Plan. No adjustments shall be made for dividends (ordinary or extraordinary, whether in cash securities, or other property)
or distribution or other rights for which the record date occurs prior to the date of such issuance, except as otherwise expressly
provided herein or as determined by the Administrator.

 

12.3
Interest. No interest shall accrue on the payroll deductions or contributions of a Participant under the Plan.

 

12.4
Designation of Beneficiary.

 

(a)
A Participant may, in the manner determined by the Administrator, file a written designation of a beneficiary who is to receive
any Shares and/or cash, if any, from the Participant’s account under the Plan in the event of such Participant’s death
subsequent to a Purchase Date on which the Participant’s rights are exercised but prior to delivery to such Participant
of such Shares and cash. In addition, a Participant may file a written designation of a beneficiary who is to receive any cash
from the Participant’s account under the Plan in the event of such Participant’s death prior to exercise of the Participant’s
rights under the Plan. If the Participant is married and resides in a community property state, a designation of a person other
than the Participant’s spouse as his or her beneficiary shall not be effective without the prior written consent of the
Participant’s spouse.

 

    13

     

    

 

(b)
Such designation of beneficiary may be changed by the Participant at any time by written notice to the Company. In the event of
the death of a Participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of
such Participant’s death, the Company shall deliver such Shares and/or cash to the executor or administrator of the estate
of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company,
in its discretion, may deliver such Shares and/or cash to the spouse or to any one or more dependents or relatives of the Participant,
or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.

 

12.5
Notices. All notices or other communications by a Participant to the Company under or in connection with the Plan shall
be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated
by the Company for the receipt thereof.

 

12.6
Equal Rights and Privileges. Subject to Section 5.7, all Eligible Employees will have equal rights and privileges
under the Section 423 Component so that the Section 423 Component of this Plan qualifies as an “employee stock purchase
plan” within the meaning of Section 423 of the Code. Subject to Section 5.7, any provision of the Section 423 Component
that is inconsistent with Section 423 of the Code will, without further act or amendment by the Company, the Board or the Administrator,
be reformed to comply with the equal rights and privileges requirement of Section 423 of the Code. Eligible Employees participating
in the Non-Section 423 Component need not have the same rights and privileges as other Eligible Employees participating in the
Non-Section 423 Component or as Eligible Employees participating in the Section 423 Component.

 

12.7
Use of Funds. All payroll deductions received or held by the Company under the Plan may be used by the Company for any
corporate purpose, and the Company shall not be obligated to segregate such payroll deductions.

 

12.8
Reports. Statements of account shall be given to Participants at least annually, which statements shall set forth the amounts
of payroll deductions, the Purchase Price, the number of Shares purchased and the remaining cash balance, if any.

 

12.9
No Employment Rights. Nothing in the Plan shall be construed to give any person (including any Eligible Employee or Participant)
the right to remain in the employ of the Company or any Parent or Subsidiary or affect the right of the Company or any Parent
or Subsidiary to terminate the employment of any person (including any Eligible Employee or Participant) at any time, with or
without cause.

 

12.10
 Notice of Disposition of Shares. Each Participant shall give prompt notice to the Company of any disposition or
other transfer of any Shares purchased upon exercise of a right under the Section 423 Component of the Plan if such disposition
or transfer is made: (a) within two years from the Enrollment Date of the Offering Period in which the Shares were purchased or
(b) within one year after the Purchase Date on which such Shares were purchased. Such notice shall specify the date of such disposition
or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other consideration, by the
Participant in such disposition or other transfer.

 

12.11
 Governing Law. The Plan and any agreements hereunder shall be administered, interpreted and enforced in accordance
with the laws of the State of Israel, disregarding any state’s choice of law principles requiring the application of a jurisdiction’s
laws other than the State of Israel. Certain definitions, which refer to the laws of such jurisdiction, shall be construed in
accordance with other such laws. The competent courts located in Tel-Aviv-Jaffa, Israel shall have exclusive jurisdiction over
any dispute arising out of or in connection with this Plan and any award granted hereunder. 

 

    14

     

    

 

12.12
 Electronic Forms. To the extent permitted by Applicable Law and in the discretion of the Administrator, an Eligible
Employee may submit any form or notice as set forth herein by means of an electronic form approved by the Administrator. Before
the commencement of an Offering Period, the Administrator shall prescribe the time limits within which any such electronic form
shall be submitted to the Administrator with respect to such Offering Period in order to be a valid election.

 

*
* * * *

 

    15ex_309265.htm

Exhibit 10.1

 

Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

 

AMENDMENT NO. 3

TO

AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT

 

This Amendment No. 3 to Amended and Restated Manufacturing and Supply Agreement (this “Amendment”), is made effective as of November 15, 2021 (hereinafter, the “Amendment Effective Date”), by and between GT MEDICAL TECHNOLOGIES, INC., a Delaware corporation having a place of business at 1809 S Holbrook Lane, Suite 107, Tempe, Arizona 85281 (“GT MED TECH”) and ISORAY MEDICAL, INC., a Delaware corporation with offices at 350 Hills Street, Suite 106, Richland, WA 99354 (“Isoray”). Capitalized terms used in this Amendment and not defined herein shall have the meanings given to such terms by the Amended and Restated Manufacturing and Supply Agreement, effective April 26, 2019, as amended (the “Agreement”).

 

WHEREAS, GT MED TECH and Isoray previously entered into the Agreement, and have previously amended the Agreement as of October 16, 2020, and previously amended the Exhibits to the Agreement as of May 28, 2019 and January 13, 2020, and now wish to further amend the Agreement for the purpose of changing the nature of the services to be provided by Isoray to GT MED TECH from and after the Supply Change Date (as defined below) from preparation of GammaTiles containing Isoray’s Seeds to Isoray only supplying Seeds to GT MED TECH so that GT MED TECH may handle the assembly of GammaTiles inhouse.

 

NOW, THEREFORE, in consideration of the mutual covenants herein contained, and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree to amend the Agreement through this Amendment as follows:

 

1.    The effective date of the changes enacted by this Amendment shall be the Amendment Effective Date.

 

2.    All references to “Product” in the Agreement are hereby amended to refer to “Seeds.”

 

3.    The text in Section 1.12 of the Agreement is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

4.    The text in Section 1.21 of the Agreement is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

5.    Section 3.1 is hereby amended and restated in its entirety as follows:

 

“3.1 Manufacture and Supply; Territory. Subject to the provisions herein, Isoray shall, manufacture and supply Seeds to GT MED TECH or end users as designated by GT MED TECH. GT MED TECH shall purchase such Seeds from Isoray, all in quantities to be set forth on purchase orders submitted from time to time by GT MED TECH in accordance with the provisions of Section 3.3. In the event (a) Isoray is unwilling or unable to supply, in compliance with the terms set forth in this Agreement, quantities of Seeds ordered by GT MED TECH in accordance with Section 3.3 and (b) GT MED TECH is at such time in full compliance with this Agreement, then GT MED TECH shall be permitted to obtain from a Third-Party manufacturer (or manufacture itself) those quantities of Seeds that Isoray is unwilling or unable to supply. At all times during the Term, any and all of Isoray's and GT MED TECH's obligations under this Agreement shall be subject to and in accordance with the provisions, limitations and conditions imposed by FDA in respect of the Seeds. On an "as needed basis" as GT MED TECH’s products including Seeds are launched in countries outside the United States, the Parties shall negotiate in good faith an amendment to this Agreement to include such additional terms as the Parties shall deem necessary to ensure compliance with applicable laws in such countries.”

 

 

1

 

 

6.    The second sentence of Section 3.3 “Purchase Orders” of the Agreement is hereby amended and restated as follows:

 

“After its receipt of a binding order form that complies with the foregoing requirements, Isoray shall promptly acknowledge in writing its receipt and acceptance of such order within four (4) business hours, and shall confirm the date(s) for delivery of Seeds; provided, however, that Isoray shall not be obligated to supply any quantities of Seeds hereunder to the extent the amount ordered in any calendar month exceeds 120% of the quantity forecasted for such calendar month in the Binding Forecast, but Isoray shall use good faith efforts to attempt to fill such orders to the extent it is reasonably able to do so. Upon Isoray’s confirmation of the binding order form, GT MED TECH shall deliver a purchase order to Isoray within four (4) business hours.”

 

7.    Section 3.4 “Order Cancellations” of the Agreement is hereby amended and restated in its entirety as follows:

 

“3.4 Order Cancellations. GT MED TECH may cancel any purchase order prior to delivery of the Seeds; provided, however, that GT MED TECH shall be obligated to pay the price per the Pricing Schedule, if applicable, for any order cancelled less than two (2) business days prior to its scheduled delivery or shipment date, whichever is earlier.

 

8.    The second sentence of Section 3.6 “Packaging and Labeling” is hereby deleted.

 

9.    Section 3.7 “Delivery” of the Agreement is hereby amended to make the existing language subsection (a) with the new heading “(a) General.” and to add the following new subsections (b), (c) and (d):

 

“(b)   Rush Orders. Rush orders are any orders requested outside of the normal delivery schedule which is defined as orders received by 4:30pm PT for delivery at 12:00pm PT the following business day. Isoray shall accept up to two (2) rush orders during each business day, and such rush orders shall be delivered in accordance with the table set forth in subsection 3.7(c). A business day is defined as 8:00am PT to 4:30pm PT Monday through Friday excluding Isoray holidays. Rush orders shall be assessed an additional fee of [**] (regardless of the number of Seeds) for the first order during any calendar week and [**] for each additional rush order during the same calendar week.

 

2

 

 

  (c)   Rush Order Delivery Timetable. For all rush orders submitted by GT MED TECH, Isoray shall deliver Seeds on the following schedule:

 

	
			For orders received by Isoray prior to:*

				
			Seeds shall be delivered by:*

			
	
			6:00 a.m.

				
			2:00 p.m. (Same day)

			
	
			12:00 p.m.

				
			9:00 a.m. (Next Day)

			
	
			4:30 p.m.

				
			12:00 p.m. (Next day)

			

  * All times are local time at Isoray facility.

 

 (d)   Good Faith Obligation. Isoray shall use commercially reasonable and good faith efforts to deliver Seeds more quickly than the delivery times specified above.

 

10.    The last sentence of new subsection 3.7(a) “General” is hereby deleted.

 

11.    The text in Section 3.9 “Changes/Engineering Change Orders” is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

12.    The text in Section 3.10 “Process Improvement Projects” is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

13.    The text in Section 3.12 “Obsolete Materials” is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

14.    The text in Section 3.13 “Reporting” is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

15.    A new Section 3.14 (newly numbered in sequence) is hereby added to the Agreement as follows:

 

“3.14         Radioactive Materials License. The Parties agree that it is their mutual intent that all orders of Seeds shall be made and all Services performed in accordance with the following provisions:

 

	 	
			(a)

				
			GT MED TECH shall periodically order Seeds from Isoray in accordance with applicable law, GT MED TECH’s radioactive materials license, and GT MED TECH’s policies and procedures relating to radiation safety.

			

 

	 	
			(b)

				
			Isoray shall periodically ship or transfer Seeds to GT MED TECH, or end user in accordance with Applicable Law, Isoray’s radioactive materials license, and Isoray’s policies and procedures relating to radiation safety. 

			

 

	 	
			(c)

				
			The Parties agree to cooperate in good faith in developing and implementing a process to safely order, purchase, and ship or transfer Seeds, which include radioactive material.

			

 

	 	
			(d)

				
			Isoray shall provide Seeds in conformity with generally accepted industry standards, Applicable Law, and the requirements of any applicable licenses and certificates.

			

 

	 	
			(e)

				
			GT MED TECH shall provide storage and handling of Seeds received from Isoray in conformity with generally accepted industry standards, Applicable Law, and the requirements of any applicable licenses and certificates.

			

 

3

 

 

16.    The text in Subsection 4.3(d) of the Agreement is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

17.    The second sentence of Section 5, and all of subsections 5.1(a), (b) and (c), of the Agreement are hereby deleted in their entirety.

 

18.    Section 5.2 of the Agreement is hereby amended to delete the phrase “and open book pricing formula for the Product as reflect in Exhibit B” but retain the remainder of such section.

 

19.    The text in Section 6 of the Agreement is hereby deleted in its entirety and replaced with “This section intentionally left blank.”. Further, within ten (10) days following the Supply Change Date, Isoray shall package and transfer to GT MED TECH’s designated location all Tools and inventory together with copies of all repair and maintenance records for the Tools, in Isoray’s possession and shall invoice GT MED TECH for the applicable freight and insurance.

 

20.    The text in Section 7.2 of the Agreement is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

21.    Section 7.3 “License to GT MED TECH” is hereby amended and restated in its entirety as follows:

 

“7.3 License to GT MED TECH. Isoray hereby grants to GT MED TECH a non- exclusive, royalty-free license to use and practice any intellectual property related to the Seeds and controlled by Isoray including any Isoray Foreground IP, solely to the extent necessary for GT MED TECH to sell and offer for sale products including the Seeds manufactured by Isoray during the Term and in accordance with the provisions of this Agreement. For the avoidance of doubt, this license permits GT MED TECH to sell the products including the Seeds manufactured by Isoray. No other use of this license by GT MED TECH is permitted.”

 

22.    The text in Section 7.4 of the Agreement is hereby deleted in its entirety and replaced with “This section intentionally left blank.”.

 

23.    Section 8.3 “Compliance with Laws” of the Agreement is hereby amended to make the existing language subsection (a) with the new heading “(a) Isoray.” and to add the following new subsection (b):

 

“(b)         GT MED TECH. GT MED TECH shall comply with Applicable Law, including those relating to transportation, storage, use, handling, and disposal of Seeds containing radioactive materials.”

 

24.    Section 8.1 “Regulatory Approvals.” is hereby amended and restated in its entirety as follows:

 

“8.1 Regulatory Approvals. GT MED TECH has obtained, or intends to obtain, Regulatory Approval to sell its GammaTile® in other jurisdictions in addition to the United States. The burden of obtaining and maintaining such Regulatory Approvals shall be on GT MED TECH. Isoray shall promptly provide such information and support to GT MED TECH as shall be reasonably requested by GT MED TECH from time to time in support of GT MED TECH’s Regulatory Approval processes in all jurisdictions for GammaTile®. From and after GT MED TECH’s receipt of Regulatory Approval in a jurisdiction, the Parties acknowledge and agree that Seeds may be sold to GT MED TECH pursuant to this Agreement for sale and use in such jurisdiction. Maintenance of the Regulatory Approval for GT MED TECH’s GammaTile® in the United States shall be the responsibility of GT MED TECH.”

 

4

 

 

25.   The first sentence of Section 8.2 “Inspections; Regulatory Action.” is hereby deleted.

 

26.    Exhibit A to the Agreement is hereby amended and restated in its entirety in the form of new Exhibit A, attached hereto and incorporated herein.

 

27.    Exhibit B to the Agreement is hereby amended and restated in its entirety in the form of new Exhibit B, attached hereto and incorporated herein.

 

28.    Exhibit C, Exhibit D and Exhibit E to the Agreement are hereby deleted in their entirety. Exhibit F shall retain its current alphabetical name.

 

29.    Except as amended herein, all other terms and conditions of the Agreement shall remain in full force and effect. Except for the specific amendments set forth herein, this Amendment shall be subject to and controlled by the terms of the Agreement. In the event of any conflict or inconsistency between any terms of this Amendment and any terms of the Agreement, the terms of this Amendment shall control and govern the rights and obligations of the Parties.

 

30.    This Amendment may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Delivery of an executed counterpart of this Amendment electronically or by facsimile shall be effective as delivery of an original executed counterpart hereof.

 

IN WITNESS WHEREOF, and intending to be legally bound hereby, the Parties have caused their authorized officers to execute this Amendment as of the Amendment Effective Date.

 

	GT MEDICAL TECHNOLOGIES, INC. 	 	ISORAY MEDICAL, INC.

 

	By:	/s/ Matthew E. Likens	 	By:	/s/ Lori A. Woods

 

	Name:	Matthew E. Likens	 	Name:	Lori A. Woods
	 	 	 	 	 
	Title:	President & CEO	 	Title:	CEO
	 	 	 	 	 
	Date:	11/16/2021	 	Date:	11/17/2021

 

5

 

 

Exhibit A

Specifications

 

GTMT Documents: DWG-3005, SP-3005.

 

 

6

 

 

Exhibit B

Pricing Schedule

 

Pricing for Seeds:

 

	
			Description

				
			Price (US$)

			
	
			Seeds (high activity Cesium-131 source)

				
			$[**] per Seed

			 

			
	
			Shipping charge for calibration Seeds

				
			Seed price, plus flat fee of $[**] for

			shipping and handling per order

			 

			
	
			Long lead time orders (more than five (5)

			calendar days between delivery to GT MED

			TECH and scheduled implantation)

				
			Seed price, plus additional handling charge of

			$[**] per Seed per day

			

* Annual price increases limited to 3% over current year price, and require not less than ninety (90) days prior written notice from Isoray to GT MED TECH before increase can go into effect for the following calendar year.

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]